The Kinase Chemogenomic Set (KCGS)

Designed to study the biology of dark kinases from the human genome

Contributors

Inventor Institute
Tim Willson The University of North Carolina at Chapel Hill ; Structural Genomics Consortium (SGC)
Cat. #: 157681
Tool sub type: 10XUAS IVS p10
Unit size: 1 plate
Research Fields: Cancer;Cancer
Application: The Kinase Chemogenomic Set (KCGS) can be used to study the biology of dark kinases from the human genome and uncover new molecular targets for drug discovery.
Product description: The Kinase Chemogenomic Set v2.0 (KCGS) is a collection of narrow-spectrum, small molecule kinase inhibitors assembled by the SGC-UNC to study the biology of understudied (“dark”) kinases. It is one of the most diverse and highly annotated, publicly available collections of kinase inhibitors. Version 2.0 builds on the original set and includes more than 280 compounds covering over 250 human kinases, providing researchers with a powerful resource for phenotypic screening and kinase biology studies. KCGS helps identify medically important kinases and supports the development of high-quality chemical probes for high-priority dark kinases of therapeutic interest. Dark kinases are those which are difficult to characterize, have limited biological information, and whose medical potential remains largely unexplored. The goal of KCGS is to generate, systematize, and disseminate knowledge about dark kinases, the biological networks in which they function, and their connections to cellular phenotypes and human disease.
Additional notes: Current batch of KCGS: CRT/KDP/26/136. Each inhibitor has been screened across hundreds of kinases and only those meeting strict selective criteria are included in the set. For more information on KCGS or for commonly asked questions, please visit https://www.sgc-unc.org/faq.
Primary target: The list of kinases covered by the inhibitors in KCGS v1.0 and v2.0 can be found in the documentation section.
Format: Frozen
Storage conditions: -80° C
Shipping conditions: Dry Ice
References:

Burdova et al. 2019. EMBO J. 38(20):e101443. PMID: 31424118.

Wells et al. 2018. Medchemcomm. 9(1):44-66. PMID: 30108900.

Drewry et al. 2017. PLoS One. 12(8):e0181585. PMID: 28767711.

Images

View Gallery

Citations And Reviews

Related Tools for Small molecules

Cat. # Tool Name
151832 LIMK inhibitor CRT0105950 Small Molecule (Tool Compound) Key Info View Tool
151839 Antitumoral Phortress Small Molecule (Tool Compound) Key Info View Tool
151843 AKR1C3 inhibitor CRT0036521 Small Molecule (Tool Compound) Key Info View Tool
152786 Nucleolar Luminophore Ag-1 Small Molecule (Tool Compound) Key Info View Tool
152788 Phosphatidylinositol-4-phosphate 5-kinase inhibitor PIP5K Small Molecule (Collaborative Toolkit) Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.